Watchlist Price Alert

Brainstorm Cell Therapeut... (BCLI)

NASDAQ: BCLI · Real-Time Price · USD

1.33

0.17 (14.66%)

At close: May 16, 2025, 3:59 PM

1.26

-5.62%

After-hours: May 16, 2025, 04:40 PM EDT

Brainstorm Cell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-11.62M	-17.19M	-24.28M	-24.46M	-31.81M	-23.25M	-13.95M	-4.95M	-4.98M
Depreciation & Amortization	240K	265K	285K	260K	219K	164K	110K	85K	77K
Stock-Based Compensation	750K	n/a	1.68M	1.37M	2.56M	789K	917K	554K	635K
Other Working Capital	160K	-3.75M	-601K	-2.05M	1.61M	234K	-2.46M	2.63M	-1.26M
Other Non-Cash Items	-147K	220K	-1.34M	n/a	n/a	n/a	102K	62K	121K
Deferred Income Tax	n/a	n/a	1.34M	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.69M	-3.75M	2.99M	-3.43M	-6.16M	11.05M	431K	1.89M	-1.71M
Operating Cash Flow	-9.09M	-20.46M	-19.32M	-26.27M	-35.19M	-11.25M	-12.39M	-2.36M	-5.86M
Capital Expenditures	n/a	-18K	-29K	-330K	-378K	-473K	-369K	-180K	-103K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	2.21M	1.03M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	12K	n/a	n/a	653K	-4.07M	6.09M	-849K	4.17M	6.08M
Investing Cash Flow	12K	2.19M	998K	323K	-4.45M	5.62M	-1.22M	3.99M	5.98M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-116K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	5K	16.32M	3.16M	12.06M	314K	n/a
Financial Cash Flow	7.97M	18.98M	238K	6.97M	76.94M	5.22M	12.06M	314K	n/a
Net Cash Flow	-1.11M	713K	-18.08M	-18.97M	37.29M	-406K	-1.54M	1.94M	119K
Free Cash Flow	-9.09M	-20.48K	-19.35M	-26.59M	-35.57M	-11.72M	-12.76M	-2.54M	-5.96M